JUBLIA Trademark
JUBLIA is a USPTO trademark filed by BAUSCH HEALTH IRELAND LIMITED. Status: Registered.
Prosecution Summary
Trademark Summary
JUBLIA is a word mark for pharmaceutical preparations and related dermatology/ophthalmological and neurological/central nervous system treatments, including antifungal preparations, pain and anxiety/depression-related pharmaceutical preparations and substances, and cardiovascular system treatment and prevention preparations. The application is a U.S. registration with registration date July 2, 2013 and is active as of January 13, 2024. The current owner identified is BAUSCH HEALTH IRELAND LIMITED. No opposition, cancellation, or other court/TTAB legal proceeding is identified in the provided record; the notable issues reflected are repeated entries stating assignment of ownership not updated automatically.
Recent Activity
The registrat
Trademark Facts
| Mark | JUBLIA |
|---|---|
| Serial Number | 85261969 |
| Registration Number | 4359772 |
| Status | Registered |
| Filing Date | 2011-03-09 |
| Registration Date | 2013-07-02 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | BAUSCH HEALTH IRELAND LIMITED |
| Attorney of Record | Jeremy Blackowicz |
| Prosecution Events | 94 |
| Latest Event | ASCK on 2026-02-18 |
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations [ ; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system ]